Lotus Eye Hospital And Institute Ltd.
Snapshot View

70.00 -1.00 ▼-1.4%

03 February 2023, 04:01:00 PM
Volume: 824

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.lotuseye.org
Market Cap 145.57 Cr.
Enterprise Value(EV) 135.46 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 2.02 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 34.69 Trailing Twelve Months Ending 2022-09
Industry PE 45.92 Trailing Twelve Months Ending 2022-09
Book Value / Share 26.86 Trailing Twelve Months Ending 2022-09
Price to Book Value 2.61 Calculated using Price: 70.00
Dividend Yield 0.71 Period Ending 2022-03
No. of Shares Subscribed 2.08 Cr. 20,796,330 Shares
FaceValue 10
Company Profile
Lotus Eye Care Hospital was originally incorporated as ‘Kalaivani Health Centre Pvt. Ltd.'on March 14,1997 under the Companies Act, 1956 vide Certificate of Incorporation issued by the Registrar of Companies, Tamil Nadu, Coimbatore. The name of the Company was changed to ‘Lotus Eye Care Hospital Pvt. Ltd. on January 23, 2006 and subsequently to ‘Lotus Eye Care Hospital Limited' upon conversion into Public Limited Company on October 16, 2007 and a fresh certificate of incorporation has been obtained from Registrar of Companies, Tamil Nadu, Coimbatore.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-1.41%
1 Week
-1.48%
1 Month
-15.56%
3 Month
+1.89%
6 Month
-0.99%
1 Year
+0.50%
2 Year
+99.71%
5 Year
+131.02%
10 Year
+771.73%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 0.08 -3.93 0.20 0.89 3.47 1.41 2.10 3.02 5.56
Return on Capital Employed (%) 0.27 -4.14 0.27 1.13 3.71 1.66 3.32 4.07 8.00
Return on Assets (%) 0.07 -3.45 0.18 0.81 3.12 1.25 1.89 2.71 4.99

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 51 49 49 50 51 50 51 53 55 56
Non Curr. Liab. 0 1 1 0 0 0 0 0 1 1
Curr. Liab. 7 6 5 4 7 6 6 6 6 7
Minority Int.
Equity & Liab. 59 56 55 55 57 56 57 58 61 64
Non Curr. Assets 52 51 48 48 49 49 47 45 48 48
Curr. Assets 7 5 6 7 8 7 11 14 13 15
Misc. Exp. not W/O
Total Assets 59 56 55 55 57 56 57 58 61 64

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 29 30 31 34 38 38 41 32 39 46
Other Income 0 0 1 1 1 1 1 1 1 1
Total Income 29 30 32 35 39 39 41 33 40 47
Total Expenditure -26 -29 -28 -31 -34 -35 -37 -29 -33 -38
PBIDT 3 2 4 4 5 4 5 4 7 9
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation -3 -4 -4 -3 -3 -3 -3 -2 -3 -3
Taxation 0 0 0 0 0 0 0 0 -1 -2
Exceptional Items 0 0 0 0 -1 0 0 0
PAT 0 -2 0 0 2 1 1 2 3 4
Adjusted EPS 0 -1 0 0 1 0 1 1 1 2

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 4 4 2 3 3 6 4 5 3 4
Cash Fr. Inv. -1 -5 -5 -1 -1 -4 -4 -1 0 -4
Cash Fr. Finan. 0 -1 2 -1 0 -2 -1 0 0 -2
Net Change 2 -1 0 2 2 0 -1 4 3 -1
Cash & Cash Eqvt 2 1 1 2 3 4 3 7 10 9

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 57.71 57.74 57.74 57.74 57.74 57.74 57.74 57.88 58.14
Public 42.29 42.26 42.26 42.26 42.26 42.26 42.26 42.12 41.86
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 4.16 4.15 4.14

Announcements View Details >>

Fri, 27 Jan 2023
Board Meeting Intimation for Intimation Of Board Meeting
Lotus Eye Hospital And Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 inter alia to consider and approve Pursuant to Regulation 29 and other applicable provisions of the SEBI (LODR) Regulations 2015 we wish to inform you that the Board of Directors of the company will be meeting on Monday February 13 2023 inter-alia to consider the following: -1. Unaudited Standalone Financial Results of the company for the quarter and year ended December 31 2022.Further with reference to our earlier intimation December 31 2022 we wish to inform that in accordance with SEBI (Prohibition of Insider Trading) Regulations 2015 and the Code of Conduct for Insiders of the Company the trading window will re-open from February 16 2023 onwards.Request you to kindly take the same on your record.
Sat, 07 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Based on the confirmation received from S.K.D.C. Consultants Limited Registrar and Transfer Agent of the company we hereby certify that the securities received for dematerialization have been mutilated and cancelled after due verification and the name of the depository has been substituted in our records as the registered owner within 15 days of receipt of certificate of security and the details are furnished to the stock exchanges.Further we certify that the securities which were dematerialized are listed on the Stock Exchanges where the earlier issued securities are listed..We request you to take this information on record.
Sat, 31 Dec 2022
Closure of Trading Window
This is to inform you that as per the SEBI (Prohibition of Insider trading ) regulations 2015 read with BSE Circular Ref No LIST/COMP/01/2019-20 and as per the terms of Code of Internal Procedures and conduct for regulating Monitoring and Reporting of Trading by Insiders of the company the trading window for dealing in the Company shares will remain closed from January 1st 2023 till the end of 48 hours after declaration of audited financial results for the quarter ending on 31st December 2022 for specified designated persons as defined in the code. The same has been informed to the Directors and designated persons of the Company.The date of Board Meeting for declaration of the financial results of the Company for the quarter ended December 31st 2022 will be intimated in the due course.

Technical Scans View Details >>

Fri, 03 Feb 2023
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above
Opening at Low Opening at Low
Close Below Last Week Low Close Below Last Week Low
High Decrease in 1 Month High Decrease in 1 Month
High Increase in 2 Years High Increase in 2 Years

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 246,567.66 1,027.65 +2.0%
Cipla Ltd. 82,812.97 1,026.00 +0.1%
Divi's Laboratories Ltd. 76,573.08 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. 72,577.66 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. 61,039.46 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. 52,289.82 1,545.00 +0.3%
Abbott India Ltd. 44,198.55 20,800.00 +1.5%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 58.54 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-12 31.39 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 25.59 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.92 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.70 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.92 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-09 50.12 20,800.00 +1.5%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.46 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-12 3.65 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 6.31 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.30 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.20 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.20 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-09 16.28 20,800.00 +1.5%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 0.04 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 0.00 20,800.00 +1.5%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 29.95 20,800.00 +1.5%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 29.95 20,800.00 +1.5%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,800.00 +1.5%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 798.70 20,800.00 +1.5%

FAQ's On Lotus Eye Hospital And Institute Ltd.

What is Lotus Eye Hospital share price?

Can I buy Lotus Eye Hospital shares now?

What is the Dividend Yield of Lotus Eye Hospital?

What is the Market Cap of Lotus Eye Hospital?

What are the key metrics to analyse Lotus Eye Hospital?

What is the 52 Week High and Low of Lotus Eye Hospital?

What is the trend of Lotus Eye Hospital share price?